Related Experiment Videos
Mesenchymal chondrosarcoma with secondary orbital invasion
S A Lauer1, S Friedland, J T Goodrich
1Department of Ophthalmology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA.
Ophthalmic Plastic and Reconstructive Surgery
|September 1, 1995
Summary
Mesenchymal chondrosarcoma invading the orbit is rare. Surgical management without exenteration, combined with adjuvant therapy, shows promising results for local tumor control in orbital cases.
Area of Science:
- Oncology
- Ophthalmology
- Surgical Pathology
Background:
- Mesenchymal chondrosarcoma is a rare bone tumor, often affecting young patients.
- Orbital involvement by mesenchymal chondrosarcoma is exceptionally uncommon.
- Historically, orbital exenteration was the standard treatment for orbital mesenchymal chondrosarcoma.
Observation:
- A case of orbital mesenchymal chondrosarcoma invading the orbit is presented.
- The patient underwent surgical tumor removal without orbital exenteration.
- Adjuvant chemotherapy and radiotherapy were administered post-operatively.
Findings:
- The patient exhibited no evidence of local or distant tumor recurrence.
- A 30-month postoperative follow-up confirmed sustained tumor control.
- This outcome challenges the necessity of exenteration for orbital mesenchymal chondrosarcoma.
Implications:
- Conservative surgical management combined with adjuvant therapies may be a viable alternative to exenteration.
- Current findings suggest that orbital exenteration might not be mandatory for achieving local tumor control.
- Further case reports and studies are warranted to validate this less invasive approach for orbital mesenchymal chondrosarcoma.